Jandersen Kapital AS, a company controlled by Kjetil Myrlid
Aasen, has today purchased 10,000 shares in PCI Biotech (at
a price of NOK 20,43). As a result of this transaction,
Aasen, including close associates, has increased his holding
in PCI Biotech to 1,247,400, or from 4.97% to 5.01% of the
outstanding shares in PCI Biotech.